Skip to content
Review Open access

The Gut Microbiome in Alzheimer's Pathology and Treatment: A Literature Review

Oct 2026 · Undergraduate Research in Natural and Clinical Science and Technology Journal · 0 citations · 27 references

Abstract

Introduction: Alzheimer's disease is a neurodegenerative disease with a complicated etiology and pathology, many aspects of which are still being investigated. Recent evidence has revealed that the composition of the gut microbiome is implicated in Alzheimer’s pathology, since gut microbes can influence the brain via a pathway known as the gut-microbiota-brain axis. Thus, the purpose of this review is to analyze whether there are consistent compositional changes associated with Alzheimer's disease, and to determine if antibiotics could serve as a mechanism of treatment for Alzheimer's.Methods: Google Scholar and PubMed were searched using keywords such as “Alzheimer’s,” “Gut microbiome”, and “Antibiotics”. Peer-reviewed studies published between 2010 and 2026, were included if they either synthesized compositional changes in gut microbiome composition in individuals with Alzheimer’s disease or tested the effects of antibiotics on modulating the gut microbiome in relationship to Alzheimer’s. Ultimately, seven papers were included in this review.Results: Surveyed studies regarding microbiome composition revealed that individuals with Alzheimer's disease tended to have substantially different microbiome compositions from those who did not, but often found conflicting results as to which taxa were associated with Alzheimer's. Surveyed studies investigating the use of antibiotics in Alzheimer's treatments found that antibiotics interchangeably improved and worsened Alzheimer's outcomes.Discussion: Although change in gut microbiome composition was not conserved across individuals with Alzheimer's, research into the metabolic functions of the altered taxa show that their functionality was largely conserved. However, this finding remains largely speculative as the authors do not integrate multiomic techniques into their study design. The discrepancies in antibiotic studies may be partially explained by varying methodologies and gut microbiome recolonization dynamics; however, the studies internal immune and metabolic findings contradict the observed effect on Alzheimer's pathology.Conclusion: This review adds to the understanding that the gut microbiome is implicated in Alzheimer's pathology and calls for more research into these areas. Additionally, it identifies several gaps and limitations in the reviewed literature, such as inconsistent methodology, a lack of multiomic integration, small sample size, and lack of sample variety, and calls for further research to fill the gaps in our understanding.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.